Dr. Steven J. Frank, Executive Director, Particle Therapy Institute, MD Anderson Cancer Center. The discussion centers on the TORPEDO trial and the broader implications of proton therapy in cancer treatment. Dr. Frank explains the advancements in precision radiation, long-term patient outcomes, and cost-effectiveness studies demonstrating how proton therapy can reduce toxicity, improve survival, and lower long-term healthcare costs.